NCT04818541View on ClinicalTrials.gov

PerQseal® Impella Early Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

March 1, 2023

Conditions
Percutaneous Large Hole Vascular Closure
Interventions
DEVICE

PPCI

Closure of the femoral access site with PerQseal device at the end of the PPCI index procedure and removal of the Impella pump.

DEVICE

Cardiogenic shock

Closure of the femoral access site with PerQseal device after removal of the Impella pump.

Trial Locations (4)

10467

Montefiore Medical Center, The Bronx

11794

Stony Brook University Hospital, Stony Brook

14203

University of Buffalo, Buffalo

07450

The Valley Hospital, Ridgewood

All Listed Sponsors
lead

Vivasure Medical Limited

INDUSTRY